Rauch, S.; Müller, H.-P.; Dreyhaupt, J.; Ludolph, A.C.; Kassubek, J.; Althaus, K.
Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study. J. Clin. Med. 2022, 11, 3399.
https://doi.org/10.3390/jcm11123399
AMA Style
Rauch S, Müller H-P, Dreyhaupt J, Ludolph AC, Kassubek J, Althaus K.
Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study. Journal of Clinical Medicine. 2022; 11(12):3399.
https://doi.org/10.3390/jcm11123399
Chicago/Turabian Style
Rauch, Sebastian, Hans-Peter Müller, Jens Dreyhaupt, Albert C. Ludolph, Jan Kassubek, and Katharina Althaus.
2022. "Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study" Journal of Clinical Medicine 11, no. 12: 3399.
https://doi.org/10.3390/jcm11123399
APA Style
Rauch, S., Müller, H.-P., Dreyhaupt, J., Ludolph, A. C., Kassubek, J., & Althaus, K.
(2022). Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study. Journal of Clinical Medicine, 11(12), 3399.
https://doi.org/10.3390/jcm11123399